Bodal ChemicalsQ2 FY25

Bodal Chemicals Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹155.7P/E: 13.6Market Cap: ₹2.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 1

Fundraise

N/A

Order

Yes

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Benzene derivatives project expected to contribute significantly from Q4 FY25, with revenue of ~Rs. 320 crore at 13%-14% EBITDA once at maximum capacity.
  • Production volume for benzene derivatives targeted to reach over 50% utilization by January FY26, ramping up further thereafter.
  • Dye intermediates division showing volume growth and better realizations; expected to deliver improved performance going forward.
  • Chlor-Alkali business anticipating further volume growth driven by increased chlorine consumption; prices improving.
  • Overall company revenue growth of 27% YoY in H1 FY25, led by volume improvement especially in intermediates.
  • Dye stuff and dye intermediates businesses expected to maintain or improve EBITDA margins above 10% in medium term.
  • Incentive approvals and government support expected to boost business post FY25 Q1.
  • Company optimistic about achieving 12%-13% EBITDA margin with contributions from benzene derivatives and Chlor Alkali segments.

See what Bodal Chemicals management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • The transcript provided does not mention any current or planned fundraising through debt or equity.
  • There is no discussion or indication from management about raising funds via capital markets or loans.
  • The focus of the call was primarily on operational performance, project updates (benzene derivatives), government incentives, and financial results.
  • No mention of new fundraising activities or plans to raise capital was made during the Q&A or management commentary.
  • The management discussed interest and depreciation costs related to the benzene derivatives project, but no new financing announcements were noted.

See what Bodal Chemicals management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company has invested in the Saykha Greenfield benzene downstream project, a strategic expansion into specialty chemicals beyond its core dye stuff and dye intermediates business.
  • This Saykha project recently achieved required quality norms and is in the process of obtaining customer certifications, especially targeting the pharmaceutical industry.
  • Production and revenue contribution from this benzene derivatives project is expected to ramp up significantly starting Q4 FY25, with major volume increases thereafter.
  • Interest and depreciation related to this project increased overheads, indicating ongoing capital investment impact.
  • Management anticipates reaching maximum capacity utilization in benzene derivatives by Q4 FY25 or Q1 FY26, implying near-term capital utilization.
  • No explicit mention of new upcoming capex projects beyond Saykha was disclosed in the call transcript.

Track Bodal Chemicals — get its next earnings analysis in your feed

How does Bodal Chemicals rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBodal Chemicals
Rev 3Mar 1

How does Bodal Chemicals rank in Chemicals & Petrochemicals?

Compare Bodal Chemicals against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →